BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

186 related articles for article (PubMed ID: 15379734)

  • 1. The macrolide-bacterium interaction and its biological basis.
    Goldman RC; Scaglione F
    Curr Drug Targets Infect Disord; 2004 Sep; 4(3):241-60. PubMed ID: 15379734
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Binding site of macrolide antibiotics on the ribosome: new resistance mutation identifies a specific interaction of ketolides with rRNA.
    Garza-Ramos G; Xiong L; Zhong P; Mankin A
    J Bacteriol; 2001 Dec; 183(23):6898-907. PubMed ID: 11698379
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Study of macrolide, lincosamide, and streptogramin B antibiotics resistance in Staphylococcus aureus].
    Matsuoka M
    Yakugaku Zasshi; 2000 Apr; 120(4):374-86. PubMed ID: 10774259
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Macrolide antibiotics in the ribosome exit tunnel: species-specific binding and action.
    Kannan K; Mankin AS
    Ann N Y Acad Sci; 2011 Dec; 1241():33-47. PubMed ID: 22191525
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Nature nurtures the design of new semi-synthetic macrolide antibiotics.
    Fernandes P; Martens E; Pereira D
    J Antibiot (Tokyo); 2017 May; 70(5):527-533. PubMed ID: 27899792
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Recent developments in macrolide antimicrobial research.
    Asaka T; Manaka A; Sugiyama H
    Curr Top Med Chem; 2003; 3(9):961-89. PubMed ID: 12678832
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Activity of the novel macrolide BAL19403 against ribosomes from erythromycin-resistant Propionibacterium acnes.
    Dreier J; Amantea E; Kellenberger L; Page MG
    Antimicrob Agents Chemother; 2007 Dec; 51(12):4361-5. PubMed ID: 17923495
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The emerging new generation of antibiotic: ketolides.
    Zhong P; Shortridge V
    Curr Drug Targets Infect Disord; 2001 Aug; 1(2):125-31. PubMed ID: 12455409
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Update on macrolide-lincosamide-streptogramin, ketolide, and oxazolidinone resistance genes.
    Roberts MC
    FEMS Microbiol Lett; 2008 May; 282(2):147-59. PubMed ID: 18399991
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Macrolide resistance mechanisms among Streptococcus pneumoniae isolated over 6 years of Canadian Respiratory Organism Susceptibility Study (CROSS) (1998 2004).
    Wierzbowski AK; Nichol K; Laing N; Hisanaga T; Nikulin A; Karlowsky JA; Hoban DJ; Zhanel GG
    J Antimicrob Chemother; 2007 Oct; 60(4):733-40. PubMed ID: 17673477
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prevalence and characterization of macrolide resistance in clinical isolates of Streptococcus pneumoniae and Streptococcus pyogenes from North America.
    Hoban DJ
    J Chemother; 2002 Jul; 14 Suppl 3():25-30. PubMed ID: 12418558
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Drugs of the 21st century: telithromycin (HMR 3647)--the first ketolide.
    Ackermann G; Rodloff AC
    J Antimicrob Chemother; 2003 Mar; 51(3):497-511. PubMed ID: 12615850
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Macrolide antibiotics: binding site, mechanism of action, resistance.
    Gaynor M; Mankin AS
    Curr Top Med Chem; 2003; 3(9):949-61. PubMed ID: 12678831
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Recent advances in the field of 16-membered macrolide antibiotics.
    Cui W; Ma S
    Mini Rev Med Chem; 2011 Oct; 11(12):1009-18. PubMed ID: 21861810
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Induction of ribosome methylation in MLS-resistant Streptococcus pneumoniae by macrolides and ketolides.
    Zhong P; Cao Z; Hammond R; Chen Y; Beyer J; Shortridge VD; Phan LY; Pratt S; Capobianco J; Reich KA; Flamm RK; Or YS; Katz L
    Microb Drug Resist; 1999; 5(3):183-8. PubMed ID: 10566867
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The macrolide binding site on the bacterial ribosome.
    Poehlsgaard J; Douthwaite S
    Curr Drug Targets Infect Disord; 2002 Mar; 2(1):67-78. PubMed ID: 12462154
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Binding and action of CEM-101, a new fluoroketolide antibiotic that inhibits protein synthesis.
    Llano-Sotelo B; Dunkle J; Klepacki D; Zhang W; Fernandes P; Cate JH; Mankin AS
    Antimicrob Agents Chemother; 2010 Dec; 54(12):4961-70. PubMed ID: 20855725
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Induction of erm(C) expression by noninducing antibiotics.
    Bailey M; Chettiath T; Mankin AS
    Antimicrob Agents Chemother; 2008 Mar; 52(3):866-74. PubMed ID: 18086834
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Structure-activity relationships of ketolides vs. macrolides.
    Douthwaite S
    Clin Microbiol Infect; 2001; 7 Suppl 3():11-7. PubMed ID: 11523556
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Role of an energy-dependent efflux pump in plasmid pNE24-mediated resistance to 14- and 15-membered macrolides in Staphylococcus epidermidis.
    Goldman RC; Capobianco JO
    Antimicrob Agents Chemother; 1990 Oct; 34(10):1973-80. PubMed ID: 1963291
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.